Cart
sales@molnova.com
EPZ020411 2HCl
CAS No. ——
EPZ020411 2HCl ( —— )
Catalog No. M17704 CAS No. ——
EPZ020411 is an effective and specific small molecule PRMT6 inhibitor (IC50=10 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 189 | Get Quote |
|
| 10MG | 301 | Get Quote |
|
| 25MG | 627 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEPZ020411 2HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionEPZ020411 is an effective and specific small molecule PRMT6 inhibitor (IC50=10 nM).
-
DescriptionEPZ020411 is an effective and specific small molecule PRMT6 inhibitor (IC50=10 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorPRMT6|PRMT1|PRMT8
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight515.51
-
Molecular FormulaC25H40Cl2N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.CNCCN(C)Cc1cnnc1c2ccc(cc2)O[C@H]4C[C@H](OCCC3CCOCC3)C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mitchell LH, et al. Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 ToolCompound. ACS Med Chem Lett. 2015 Apr 6;6(6):655-659.
molnova catalog
related products
-
CPG-52364
CPG-52364 (CPG52364) is an orally available, small molecule TLR7/8/9 antagonist for the treatment of systemic lupus erythematosus and other autoimmune disorders.
-
Loxoribine
Loxoribine is a guanosine analog. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist. It has anti-viral and anti-tumor activities.Loxoribine is a potent new immunostimulant with a relatively broad spectrum of immunobiological activities.
-
ODN 1826
ODN 1826 is a 20-mer DNA strand, a TLR9 agonist and an immunostimulant, with anti-tumor and cardioprotective effects, promoting apoptosis, and stimulating the production of NO and iNOS. ODN 1826 is a CpG DNA mimetic that can be used as an adjuvant for synthetic vaccines.
